Skip to main content
Log in

Cost Savings with Antacid Treatment?

  • Current Comment
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • O’Connor TW, Pisano DP. Estimated cost savings through the use of antacid treatment as an alternative to H2 histamine antagonists. Advances in Therapy 8: 305–316, 1991

    Google Scholar 

  • Bulpitt CJR. Randomized Controlled Clinical Trials. The Hague: Maninus Nijhoff, 191–192, 1983

    Google Scholar 

  • Doubilet P, Weinstein MC, McNeil B. Occasional notes. Use and misuse of the term ‘cost effective’ in Medicine. New England Journal of Medicine 314: 253–256, 1986

    Article  PubMed  CAS  Google Scholar 

  • Pym B, Sanstad J, Seville P, Byth K, Middleton WRJ, et al. Cost-effectiveness of cimetidine maintenance therapy in patients with chronic gastric or duodenal ulcer. Gastroenterology 99: 22–35, 1990

    Google Scholar 

  • Sonnenberg A. Costs of medical and surgical treatment of duodenal ulcer. Gastroenterology 96: 1445–1452, 1989

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piper, D.W. Cost Savings with Antacid Treatment?. Pharmacoeconomics 3, 173–175 (1993). https://doi.org/10.2165/00019053-199303020-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199303020-00009

Keywords

Navigation